Further In Vitro and Ex Vivo Pharmacological and Kinetic Characterizations of CCF219B: A Positive Allosteric Modulator of the α<sub>1A</sub>-Adrenergic Receptor

<b>Background:</b> Alterations in the adrenergic system have been associated with the pathophysiology of Alzheimer’s disease (AD). A novel α<sub>1A</sub>-adrenergic receptor (AR)-positive allosteric modulator (PAM), CCF219B, has been shown to outperform donepezil with rescue...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: Robert S. Papay, Dianne M. Perez
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Subjects:
Alzheimer’s disease
adrenergic receptor
GPCR
allosteric modulator
kinetics
Online Access:https://www.mdpi.com/1424-8247/18/4/476

Internet

https://www.mdpi.com/1424-8247/18/4/476

Similar Items